1. Home
  2. BH vs PCRX Comparison

BH vs PCRX Comparison

Compare BH & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biglari Holdings Inc. Class B

BH

Biglari Holdings Inc. Class B

HOLD

Current Price

$420.02

Market Cap

1.0B

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.59

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BH
PCRX
Founded
1934
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
BH
PCRX
Price
$420.02
$23.59
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$32.86
AVG Volume (30 Days)
60.2K
965.3K
Earning Date
11-07-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.91
0.47
Revenue
$386,507,000.00
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
N/A
$9.53
P/E Ratio
$628.45
$49.92
Revenue Growth
6.87
3.14
52 Week Low
$195.05
$19.81
52 Week High
$424.48
$27.64

Technical Indicators

Market Signals
Indicator
BH
PCRX
Relative Strength Index (RSI) 78.10 40.40
Support Level $346.56 $24.20
Resistance Level $364.95 $26.48
Average True Range (ATR) 15.80 1.06
MACD 7.27 -0.23
Stochastic Oscillator 100.00 29.39

Price Performance

Historical Comparison
BH
PCRX

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: